Search

Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality following heart transplantation (HT). Prior studies identified distinct CAV trajectories in the early post‐HT period with unique predictors, but the evolution of CAV in later periods is not well‐described. This study assessed the prevalence of late CAV progression and associated risk factors in HT recipients with ISHLT CAV 0/1 at 10 years post‐HT. Consecutive adult patients who underwent HT from January 2000 to December 2008 were evaluated and grouped by CAV trajectories into progressors (developed ISHLT CAV 2/3) or nonprogressors (remained ISHLT CAV 0/1). A total of 130 patients were included with a median age at angiography of 61.7 years and a median follow‐up time of 4.8 years. 8.5% progressed to CAV 2/3, while the remaining 91.5% were nonprogressors. Progression was not associated with death or retransplantation (27.3% [progressor] vs. 21.0% [nonprogressor], p = 0.70). These data may inform shared decision‐making about late CAV screening. [ABSTRACT FROM AUTHOR]

Introduction: Accurate volume status monitoring is crucial for effective diuretic therapy in patients with acute decompensated heart failure (ADHF). While guidelines recommend daily standing body weight measurement as an indicator of volume status, bed scales are commonly used in healthcare facilities. Methods: A method-comparison design was used to compare bed and standing scale weights among adults hospitalized with ADHF at Los Angeles County–University of Southern California Medical Center between March and April 2023. Results & Conclusion: Among 51 weight pairs from 43 participants, a clinically significant mean difference of 1.42 ± 1.18 kg was observed, exceeding the recommended threshold. Inaccuracies, with 71% showing differences >0.6 kg, highlight potential fluid management errors when relying on bed scales in ADHF hospitalizations. Article highlights Heart failure affects 6.5 million Americans, with acute decompensated heart failure causing over 1 million annual inpatient admissions with significant healthcare costs. Accurate weight measurement is essential in determining a patient's volume status and titrating diuresis, a mainstay of therapy, in order to reduce hospitalization duration and prevent readmission. Guidelines recommend daily monitoring of standing body weight, though many hospitals use bed scales instead. This study compared weights obtained via bed and standing scales among patients hospitalized with acute decompensated heart failure. Bed scale weights were inaccurate compared with standing scale weights, with a mean difference of 1.42 ± 1.18 kg (95% CI: -0.894 to 3.73), exceeding the recommended threshold. Factors contributing to inaccuracies include inadequate bed calibration and the presence of extra items during in-bed weighing. Inaccuracies in bed scale weights highlight the need for reform in this current standard practice of care in order to avoid potential errors in medical management, reduce readmission, and facilitate the self-monitoring of patients' weights at home. [ABSTRACT FROM AUTHOR]